01 14Cimzia
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 1,866
2018 Revenue in Millions : 1,576
Growth (%) : 18
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 89
2019 Revenue in Millions : 85
Growth (%) : 4
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 2,176
2019 Revenue in Millions : 2,071
Growth (%) : 5
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 93
2020 Revenue in Millions : 88
Growth (%) : 13
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 2,027
2020 Revenue in Millions : 2,176
Growth (%) : 2
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 85
2021 Revenue in Millions : 95
Growth (%) : -10
Main Therapeutic Indication : Dermatology
Currency : USD
2022 Revenue in Millions : 2,223
2021 Revenue in Millions : 2,027
Growth (%) : 10
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 2,254
2022 Revenue in Millions : 2,223
Growth (%) : 0
Main Therapeutic Indication : Immunology
Currency : USD
2024 Revenue in Millions : 2,134
2023 Revenue in Millions : 2,254
Growth (%) : -5
Main Therapeutic Indication : Anti-Inflammatory
Currency : USD
2018 Revenue in Millions : 84
2017 Revenue in Millions : 79
Growth (%) : 6%
